1 The agonist-specific coupling properties of the three cloned human alpha
(2)-adrenoceptor subtypes have been compared, when expressed at similar lev
els in Chinese hamster ovary (CHO) cell lines, using noradrenaline and (+/-
)-meta-octopamine as agonists.
2 Noradrenaline can couple the receptor to both the inhibition and stimulat
ion of forskolin-stimulated cyclic AMP production in all three receptor sub
types, with the relative strength of the coupling to the pathways varying f
or each of the receptor subtypes.
3 meta-Octopamine selectively couples the alpha (2A)-adrenoceptor only to t
he inhibition of forskolin-stimulated cyclic AMP production. However, meta-
octopamine couples the alpha (2B)- and alpha (2C)-adrenoceptors to both the
inhibition and stimulation of forskolin-stimulated cyclic AMP production.
4 The relative potency of meta-octopamine to noradrenaline varies between t
he different alpha (2)-adrenoceptor subtypes. The effects of meta-octopamin
e are around two orders of magnitude less potent than those of noradrenalin
e on both the alpha (2A)- and alpha (2B)-adrenoceptor subtypes. In contrast
, in the case of the alpha (2C)-adrenoceptor, meta-octopamine is only one o
rder of magnitude less potent than noradrenaline in the stimulation of fors
kolin-stimulated cyclic AMP production and, in addition, is equipotent with
noradrenaline in the inhibition of forskolin-stimulated cyclic AMP product
ion and has an increased maximal response. This raises the possibility that
,meta-octopamine may have physiologically important actions via alpha (2C)-
adrenoceptors in vivo.
5 The results show that the modulation of cyclic AMP production occurs in b
oth a subtype- and agonist-specific manner for alpha (2A)-adrenoceptors and
in a subtype specific manner for alpha (2B)- and alpha (2C)-adrenoceptors.